These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20575089)

  • 1. Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes.
    Hayes D; West SE; Rock MJ; Li Z; Splaingard ML; Farrell PM
    Pediatr Pulmonol; 2010 Jul; 45(7):708-16. PubMed ID: 20575089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis.
    Farrell PM; Shen G; Splaingard M; Colby CE; Laxova A; Kosorok MR; Rock MJ; Mischler EH
    Pediatrics; 1997 Nov; 100(5):E2. PubMed ID: 9346996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.
    Tümmler B; Koopmann U; Grothues D; Weissbrodt H; Steinkamp G; von der Hardt H
    J Clin Microbiol; 1991 Jun; 29(6):1265-7. PubMed ID: 1907611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Pseudomonas aeruginosa detection in children after separation of pediatric from adult cystic fibrosis clinics: A single center experience.
    Barnes LA; Gaillard PR; Menk JS; Wey AR; Regelmann WE; Demirel N
    Pediatr Pulmonol; 2018 Dec; 53(12):1604-1610. PubMed ID: 30353693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
    West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM
    JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.
    Kosorok MR; Zeng L; West SE; Rock MJ; Splaingard ML; Laxova A; Green CG; Collins J; Farrell PM
    Pediatr Pulmonol; 2001 Oct; 32(4):277-87. PubMed ID: 11568988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening.
    Hayes D; Farrell PM; Li Z; West SE
    Pediatr Pulmonol; 2010 Jan; 45(1):55-61. PubMed ID: 20025049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
    Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
    J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosis.
    Daines C; VanDeVanter D; Khan U; Emerson J; Heltshe S; McNamara S; Anstead M; Langkamp M; Doring G; Ratjen F; Ramsey B; Gibson RL; Morgan W; Rosenfeld M;
    J Cyst Fibros; 2014 Sep; 13(5):542-9. PubMed ID: 25027419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL; Desai H; Platt M; Dixon M
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
    Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
    Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis.
    Heltshe SL; Khan U; Beckett V; Baines A; Emerson J; Sanders DB; Gibson RL; Morgan W; Rosenfeld M
    J Cyst Fibros; 2018 May; 17(3):341-347. PubMed ID: 29110966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
    Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years.
    Kidd TJ; Ramsay KA; Vidmar S; Carlin JB; Bell SC; Wainwright CE; Grimwood K;
    J Cyst Fibros; 2015 May; 14(3):361-9. PubMed ID: 25563522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization.
    Munck A; Bonacorsi S; Mariani-Kurkdjian P; Lebourgeois M; Gérardin M; Brahimi N; Navarro J; Bingen E
    Pediatr Pulmonol; 2001 Oct; 32(4):288-92. PubMed ID: 11568989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.
    Tiddens HA; De Boeck K; Clancy JP; Fayon M; H G M A; Bresnik M; Derchak A; Lewis SA; Oermann CM;
    J Cyst Fibros; 2015 Jan; 14(1):111-9. PubMed ID: 25091537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
    Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
    J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: A registry-based longitudinal study.
    Wang SS; FitzSimmons SC; O'Leary LA; Rock MJ; Gwinn ML; Khoury MJ
    Pediatrics; 2001 Feb; 107(2):274-9. PubMed ID: 11158458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.
    Kosorok MR; Jalaluddin M; Farrell PM; Shen G; Colby CE; Laxova A; Rock MJ; Splaingard M
    Pediatr Pulmonol; 1998 Aug; 26(2):81-8. PubMed ID: 9727757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.